Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OXY-NASE NASAL DROPS 0.025% - HSA Drug Approval Details

Approvals/HSA/OXY-NASE NASAL DROPS 0.025%

Approved

THERAPEUTIC

OXY-NASE NASAL DROPS 0.025%

HOE PHARMACEUTICALS SDN BHD🇸🇬 Health Sciences Authority

Approval Date: Feb 4, 1998
Approval ID: e400a1d6fe9e7408
Company: HOE PHARMACEUTICALS SDN BHD
Type: Therapeutic

Approval Details

Approval Id: e400a1d6fe9e7408
Drug Name: OXY-NASE NASAL DROPS 0.025%
Product Name: OXY-NASE NASAL DROPS 0.025%
Approval Number: SIN09618P
Approval Date: 1998-02-04
Registrant: ZUELLIG PHARMA PTE. LTD.
Licence Holder: ZUELLIG PHARMA PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SOLUTION
Route Of Administration: NASAL
Atc Code: R01AA05
Atc Item Name: oxymetazoline
Pharma Manufacturer Name: ZUELLIG PHARMA PTE. LTD.
Company Detail Path: /organization/zuellig-pharma-pte-ltd

Active Ingredients

OXYMETAZOLINE HCl

0.025% w/v

OXYMETAZOLINE HCL

0.025% W/V

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 4, 1998

Approval ID

e400a1d6fe9e7408

Type

Therapeutic

Back to HSA Approvals